
Anal Cancer 2025 UPDATE
Two Onc Docs
00:00
2025 Update: Retifanlimab with Carboplatin–Paclitaxel
They present the May 2025 FDA approval of retifanlimab plus carboplatin/paclitaxel from the PODIUM-303 trial.
Play episode from 07:31
Transcript

They present the May 2025 FDA approval of retifanlimab plus carboplatin/paclitaxel from the PODIUM-303 trial.